e-learning
resources
Virtual 2021
05.09.2021
Pulmonary embolism in non-COVID-19 and COVID-19 patients
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Compliance with BTS and NICE guidelines in assessment of possible pulmonary embolism
A. Akhtar (Barnsley (South Yorkshire), United Kingdom), M. Usman (Barnsley (South Yorkshire), United Kingdom), H. Azam (Manchester, United Kingdom)
Source:
Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients
Session:
Pulmonary embolism in non-COVID-19 and COVID-19 patients
Session type:
E-poster
Number:
493
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Akhtar (Barnsley (South Yorkshire), United Kingdom), M. Usman (Barnsley (South Yorkshire), United Kingdom), H. Azam (Manchester, United Kingdom). Compliance with BTS and NICE guidelines in assessment of possible pulmonary embolism. 493
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism
Features of patients newly diagnosed pulmonary embolism during COVID pneumonia
Diagnosis and treatment of chronic pulmonary embolism
Related content which might interest you:
What is new in the 2019 ESC/ERS guidelines for the management of pulmonary embolism?
Source: International Congress 2019 – Breathing disorders, cardiovascular disease and pulmonary embolism guidelines
Year: 2019
Impact of guidelines for the management of pulmonary embolism in clinical practice
Source: International Congress 2019 – Breathing disorders, cardiovascular disease and pulmonary embolism guidelines
Year: 2019
The 2014 ESC pulmonary embolism guidelines
Source: International Congress 2014 – The ERJ and ERR at the forefront of respiratory medicine: 2014 guidelines
Year: 2014
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Source: Guideline 2015
Year: 2021
Management of pulmonary embolism: recent evidence and the new European guidelines
Source: Eur Respir J 2014; 44: 1385-1390
Year: 2014
WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension
Source: Eur Respir Rev, 31 (163) 210165; 10.1183/16000617.0165-2021
Year: 2022
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
Source: Eur Respir J, 50 (2) 1700889; 10.1183/13993003.00889-2017
Year: 2017
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
Source: Eur Respir J, 54 (3) 1901647; 10.1183/13993003.01647-2019
Year: 2019
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
Source: Guideline 2019
Year: 2019
Guidelines for the diagnosis and treatment of pulmonary hypertension
Source: Guideline 2009
Year: 2009
Guidelines for the diagnosis and treatment of pulmonary hypertension
Source: Eur Respir J 2009; 34: 1219-1263
Year: 2009
Recommendations of the ATS/ERS Task Force for the definition of outcomes for COPD pharmacological trials
Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers
Year: 2006
Pulmonary hypertension: new guidelines for therapy
Source: Annual Congress 2007 - PG19 - Pulmonary vascular disorders: diagnosis and treatment
Year: 2007
Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre
Source: Guideline 2009
Year: 2009
Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre
Source: Eur Respir Rev 2009; 18: 272-290
Year: 2009
Compliance with recommendation for respiratory sampling in diagnosis of Tuberculosis(NICE guideline NG33)
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018
Guideline methodology in the ERS/ATS COPD exacerbation guidelines
Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention
Year: 2013
The cost of pulmonary embolism treatment with different anticoagulation strategies in Turkey
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015
Contact tracing in pulmonary versus non-pulmonary tuberculosis- the impact of the 2016 NICE guidelines?
Source: International Congress 2017 – Migrants and screening
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept